TREATMENT OF NORMAL DONORS WITH RHG-CSF 16 MU-G KG FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS AND THEIR APHERETIC COLLECTION FOR ALLOGENEIC TRANSPLANTATION/
I. Majolino et al., TREATMENT OF NORMAL DONORS WITH RHG-CSF 16 MU-G KG FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS AND THEIR APHERETIC COLLECTION FOR ALLOGENEIC TRANSPLANTATION/, Haematologica, 80(3), 1995, pp. 219-226
Background. Utilization of peripheral blood stem cells (PBSC) in allog
eneic transplantation requires a method for their mobilization and col
lection that is not inconvenient for the donor. Methods. We administer
ed rhG-CSF (filgrastim) 16 mu g/kg subcutaneously for 4 days in five n
ormal subjects (age 18-31, M=3, F=2), previously selected as HLA-ident
ical donors of siblings with leukemia. Ah the donors gave written info
rmed consent. On days 4 and 5 (in one donor on day 6 too), 10:11leukap
heretic collection was performed with a CS-3000 (Baxter) or an AS-104
(Fresenius) cell separator through the antecubital vein. Results. The
WBC count reached a median peak of 57.0x10(9)/L, on day 5. The periphe
ral blood CFU-GM peaked to a median level of 8908/mL on day 5 with a m
edian increase over baseline values of 39.1 times. The CD34(+) cells p
eaked to (median) 147.0x10(6)/L on day 4 with a median increase of 65.
3 times. A lesser enrichment was recorded for BFU-E (median increase 1
2.7 times) and CFU-GEMM (median increase 15.2 times). Even CD3(+) and
CD56(+)CD3(-) cells increased (median 1.7 and 1.5 times, respectively)
. A median of 771x10(8) MNC (range 672-1378), 116.4x10(6) CFU-GM (rang
e 47.7-145.1) and 754x10(6) CD34(+) cells (range 477-2599) were aphere
tically collected. Concerning side effects, mild to moderate back pain
and general minor discomfort were reported by all donors. The platele
t level regularly but transiently decreased after completion of the ap
heretic procedures with a median nadir of 69x10(9)/L (range 43-126) on
(median) day 7, but in no case did thrombocytopenia cause bleeding. T
he thrombocytopenia was more pronounced with the CS-3000 than the AS-1
04 apparatus. Conclusions. rhG-CSF 16 mu g/kgx4 days is an efficient s
chedule for PBSC mobilization in healthy donors, but lower doses and e
ven a single apheresis procedure might prove similarly adequate.